14.00 - 17.30
14.00 - 14.30 Fetomaternal immunology
14.00 - 14.30 TOWARDS A PROPHYLACTIC TREATMENT OF HPA-1A-RELATED FETAL
AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT)
A. Husebekk (Norway)
14.30 - 14.45 FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: AN UPDATE ON
PRIVATE AND RARE HUMAN PLATELET ANTIGENS
G. Bertrand (France)
14.45 - 15.00 HPA GENOTYPING IN PREGNANT WOMEN: VALIDATION OF ID-HPA XMAP
LUMINEXⓇ TECHNOLOGY
D. Londero (Italy)
15.00 - 15.15 TITRATION OF IgG ANTIBODIES IN PREGNANCY - A SNAPSHOT OF
PERFORMANCE AND POLICY IN THE UK
J.L. White (United Kingdom)
15.15 - 15.30 ROUTINE ANTENATAL ANTI-D PROPHYLAXIS AND PATIENT COMPLIANCE
R. Steffensen (Denmark)
14.00 - 15.30 Working Party on Quality Management
14.00 - 14.15 PLATELET RICH PLASMA VS BUFFY COAT METHOD - IN VITRO QUALITY
ASSESSMENT OF RANDOM DONOR PLATELET CONCENTRATE BY A TERTIARY
CARE HOSPITAL IN INDIA
S. Agarwal (India)
14.15 - 14.30 MANAGED CONVERGENCE, A POTENTIAL COLLABORATION BETWEEN BLOOD
ESTABLISHMENTS, SUPPLIERS AND REGULATORS: IMPROVING SAFETY OF
APHERESIS CONNECTORS
G. Folléa (Belgium)
14.30 - 14.45 MEXICAN PROGRAM FOR EXTERNAL QUALITY ASSURANCE IN INFECTIOUS
SEROLOGY, GENERAL RESULTS OF THE FIRST YEAR OF ACTIVITIES, INSTITUTO
LICON
P.E. Sánchez-Montero (Mexico)
14.45 - 15.00 ESTABLISHMENT OF A NATIONAL ACCREDITATION PROGRAM FOR BLOOD BANKS
(BB) IN INDIA UNDER NATIONAL ACCREDITATION BOARD OF HOSPITALS AND
HEALTHCARE PROVIDERS (NABH)
N. Choudhury (India)
15.00 - 15.15 SURVEY OF QUALITY ASSURANCE IN HEMOTHERAPY IN THE VARIOUS MEDICAL
FACILITIES
B. Gathof (Germany)
14.00 - 15.30 Emergency planning and outcome
14.00 - 14.30 Restoring blood production in Haiti after the earthquake of January 12th,
2010
E. Noel (Haiti)
14.30 - 15.00 The Oslo massacre 2011
C. Akkök (Norway)
15.00 - 15.30 Blood supply system in Mexico
J. Rojo Medina (Mexico)
14.00 - 15.30 Donor adverse events
14.00 - 14.30 DONOR VIGILANCE: PROGRESS AND CHALLENGES
J.C Wiersum-Osselton (The Netherlands)
14.30 - 14.45 IRON AND CARDIAC ISCHEMIA: A NATURAL, QUASI-RANDOM EXPERIMENT
COMPARING ELIGIBLE WITH DISQUALIFIED BLOOD DONORS
M. Germain (Canada)
14.45 - 15.00 FREQUENCY AND RISK FACTORS FOR DONOR REACTIONS
R. Goldman (Canada)
15.00 - 15.15 REDUCING THE RISK OF PRE-SYNCOPE AND SYNCOPE IN HIGH VOLUME
PLASMAPHERESIS COLLECTIONS
B.M. Bell (Australia)
15.15 - 15.30 Overall Discussion
14.00 - 15.30 Training and Education
14.00 - 14.18 MANAGEMENT AND IMPLEMENTATION OF CONTINUING EDUCATION IN BLOOD
CENTER OF ZHEJIANG PROVINCE
B. Dai (China)
14.18 - 14.36 A 'WIN-WIN' APPROACH TO SUCCESSFULLY IMPLEMENT COMPETENCY
ASSESSMENT FOR ALL MEDICAL TRAINEES AT A TERTIARY LEVEL LONDON
TEACHING HOSPITAL
M. Sekhar (United Kingdom)
14.36 - 14.54 DEVELOPING A PACIFIC TRANSFUSION LEADERSHIP NETWORK TO STRENGTHEN
REGIONAL TRANSFUSION PRACTICE
N. Waters (Australia)
14.54 - 15.12 THE ROLE OF TRAINING AND EDUCATION IN IMPROVING QUALITY IN BLOOD
TRANSFUSION SERVICES
M.T. Bahgat (Egypt)
15.12 - 15.30 ISBT Developing Country Award
DEVELOPMENT OF TRAINING AND EDUCATION IN TRANSFUSION MEDICINE IN SRI
LANKA
S. Jayasekara (Sri Lanka)
15.30 - 16.00 Coffee Break
16.00 - 17.30 New blood groups
16.00 - 16.30 IDENTIFICATION OF HUMAN ATP-BINDING CASSETTE (ABC) TRANSPORTERS AS
CARRIERS OF HIGH-INCIDENCE ANTIGENS IN TWO NOVEL BLOOD GROUP SYSTEMS
L. Arnaud (France)
16.30 - 17.00 THE JR BLOOD GROUP SYSTEM: GENETIC AND MOLECULAR INVESTIGATIONS
M. Reid (USA)
17.00 - 17.15 A NOVEL CROMER BLOOD GROUP SYSTEM ANTIGEN, CRUE, ARISING FROM TWO
HETEROZYGOUS DAF MUTATIONS IN ONE INDIVIDUAL WITH THE CORRESPONDING
ANTI-CRUE
V. Karamatic Crew (United Kingdom)
17.15 - 17.30 PARG: A NEW LOW PREVALENCE RH BLOOD GROUP ANTIGEN
A. Scharberg (Germany)
16.00 - 17.30 Chagas disease
16.00 - 16.30 CHAGAS DISEASE: A THREAT FOR SAFE BLOOD TRANSFUSION?
M.A. Shikanai Yasuda (Brazil)
17.00 - 17.30 STRATEGIES FOR CHAGAS PREVENTION IN MEXICO
A. Malagón Martínez (Mexico)
17.30 - 17.45 NO EVIDENCE OF TRYPANOSOMA CRUZI INCIDENCE IN UNITED STATES BLOOD
DONORS: A 4-YEAR STUDY
L. Stramer (USA)
17.45 - 18.00 TRYPANOSOMA CRUZI PARASITEMIA STATUS DETERMINED BY A SENSITIVE,
QUANTITATIVE PCR ASSAY CORRELATES WITH CLINICAL MANIFESTATIONS OF
CHAGAS HEART DISEASE IN A COHORT OF SEROPOSITIVE BLOOD DONORS
M. Busch (USA)
16.00 - 17.30 Appropriate use of RBCs
16.00 - 16.30 PATTERNS OF BLOOD USE: HOW TO DEAL WITH OVERCONSUMPTION
K. Titlestad (Denmark)
16.30 - 16.45 TRANSFUSION RISK SCORE AND BLOOD USE IN CARDIAC SURGERY PATIENTS: A
CARDIOVASCULAR HOSPITAL EXPERIENCE IN BOGOTÁ, COLOMBIA
O. Penuela (Colombia)
16.45 - 17.00 DESIGNING A STRATEGY TO IMPLEMENT A COST-EFFECTIVE BLOOD TRANSFUSION
POLICY IN ELECTIVE HIP AND KNEE ARTHROPLASTIES: A STUDY PROTOCOL
V.M.A. Voorn (Netherlands)
17.00 - 17.15 EVIDENCE-BASED PATIENT BLOOD MANAGEMENT GUIDELINES FOR MEDICAL
PATIENTS
M. Dean (Australia)
17.15 - 17.30 RBC TRANSFUSION PRACTICE IN GENERAL SURGERY, EXPERIENCE FROM A SINGLE
PORTUGUESE CENTRE
A. Spinola (Portugal)
16.00 - 17.30 Working Party on Rare Donors
16.00 - 16.15 INTRODUCTION TO PROGRAMME
S. Nance (USA)
16.15 - 16.30 NATIONAL RARE DONOR PROGRAM EXPERIENCE AND CHALLENGES
C. Olsen (South Africa)
16.30 - 16.45 REGIONAL NETWORK RARE DONOR PROGRAM EXPERIENCE AND CHALLENGES
E. Muñiz-Diaz (Spain)
16.45 - 17.00 STARTING A RARE DONOR PROGRAM EXPERIENCE AND CHALLENGES
M. Moghaddam (Iran)
17.00 - 17.30 THE GLOBAL EXPERIENCE: INTERNATIONAL RARE DONOR PANEL
J. Poole (United Kingdom)
16.00 - 17.30 Working Party on IT
16.00 - 16.30 FROM INSPIRATION TO IMPLEMENTATION
C. Hohberger (USA)
16.30 - 16.50 OPTIMIZE OVERALL PERFORMANCE OF TRANSFUSION WITH APPROPRIATE IT
SOLUTIONS
L. Briggs (USA)
16.50 - 17.10 ACCEPTANCE ANALYSIS AND PILOT TESTING OF A NEW ELECTRONIC BLOOD
DONOR ID-CARD AT GERMAN RED CROSS BLOOD DONATION SERVICES
R. Knels (Germany)
17.10 - 17.30 ELECTRONICAL ADMINISTRATION AND ARCHIVING OF QUALITY MANAGEMENT
DOCUMENTS
T. Müller-Kuller (Germany)
16.00 - 17.30 Cellular therapy in regenerative medicine
16.00 - 16.30 STEM CELL THERAPY IN CARDIAC DISEASES
A.C. Campos de Carvalho (Brazil)
16.30 - 17.00 CHALLENGES FOR SUCCESSFUL TRANSLATION OF CELLULAR THERAPY
K.C. Gunter (USA)
17.00 - 17.30 STEM CELL DONOR REGISTRIES: DONOR SEARCH AND ITS IMPACT ON THE CLINICAL
OUTCOME OF PATIENST WITH MALIGNANT HEMATOLOGICAL DISEASES
E. Seifried (Germany)
19.30 - 23.00 Congress Party
